A Study of LY3337641 in Rheumatoid Arthritis

Clinical trial NCT02628028 · TERMINATED

Trial details

NCT number: NCT02628028
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2016-08-22
Primary completion: 2018-04-25
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.